HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protective effects of antithrombin on puromycin aminonucleoside nephrosis in rats.

Abstract
We investigated the effects of antithrombin, a plasma inhibitor of coagulation factors, in rats with puromycin aminonucleoside-induced nephrosis, which is an experimental model of human nephrotic syndrome. Antithrombin (50 or 500 IU/kg/i.v.) was administered to rats once a day for 10 days immediately after the injection of puromycin aminonucleoside (50 mg/kg/i.v.). Treatment with antithrombin attenuated the puromycin aminonucleoside-induced hematological abnormalities. Puromycin aminonucleoside-induced renal dysfunction and hyperlipidemia were also suppressed. Histopathological examination revealed severe renal damage such as proteinaceous casts in tubuli and tubular expansion in the kidney of control rats, while an improvement of the damage was seen in antithrombin-treated rats. In addition, antithrombin treatment markedly suppressed puromycin aminonucleoside-induced apoptosis of renal tubular epithelial cells. Furthermore, puromycin aminonucleoside-induced increases in renal cytokine content were also decreased. These findings suggest that thrombin plays an important role in the pathogenesis of puromycin aminonucleoside-induced nephrotic syndrome. Treatment with antithrombin may be clinically effective in patients with nephrotic syndrome.
AuthorsJunji Yamashita, Kenji Nakajima, Yoichi Ohno, Yoshiaki Kaneshiro, Takato Matsuo, Hitoshi Tanaka, Kenji Kaneko
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 589 Issue 1-3 Pg. 239-44 (Jul 28 2008) ISSN: 0014-2999 [Print] Netherlands
PMID18541230 (Publication Type: Journal Article)
Chemical References
  • Anticoagulants
  • Antithrombins
  • Cytokines
  • Puromycin Aminonucleoside
  • Thrombin
Topics
  • Animals
  • Anticoagulants (administration & dosage, pharmacology)
  • Antithrombins (administration & dosage, pharmacology)
  • Apoptosis (drug effects)
  • Blood Coagulation (drug effects)
  • Cytokines (metabolism)
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Hyperlipidemias (metabolism, prevention & control)
  • In Situ Nick-End Labeling
  • Injections, Intravenous
  • Kidney (drug effects, metabolism, pathology)
  • Nephrotic Syndrome (blood, chemically induced, pathology, prevention & control)
  • Proteinuria (metabolism, prevention & control)
  • Puromycin Aminonucleoside
  • Rats
  • Thrombin (antagonists & inhibitors, metabolism)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: